Event Date/Time: Jan 15, 2010
End Date/Time: Jan 15, 2010
Advances in neuro-oncology has increased our understanding of the molecular biology of brain tumors. Advances in surgical techniques and intraoperative imaging have improved outcomes. We have seen an integration of newly identified molecular biomarkers into clinical trials in an effort to provide individualized patient treatments. The use of non-invasive methods of detecting tumor proliferation, invasion and angiogenesis within the brain is rapidly growing. Every day brings us closer to the promise that molecular profiling of tumors will predict tumor response to therapy and guide clinical management decisions.
At the conclusion of this activity, participants should be able to:
*Evaluate and manage the medical and neurological complications of brain tumors
*Describe the latest breakthroughs in the multidisciplinary treatment of primary brain tumors
*Discuss the roles of the multidisciplinary team that specializes in the care of patients with brain tumors
*Analyze and manage neurological complications in the patient with cancer